Eurofins Scientific banks €535m for Covid-19 testing

By Sam Kerr
19 May 2020

Eurofins Scientific, the French-listed bio-analytical testing company, completed a €535m capital raise on Monday night, to fund investments and capital needs for more Covid-19 testing.

Berenberg and Credit Suisse were the bookrunners on the deal, which was launched after a wall-crossing exercise.

The company originally set out to sell 900,000 new shares as part of the raise but grew the deal to 1m shares on the strength of demand.

The final price ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial